EBITDA: Income before interest, taxes, depreciation and amortization.
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had EBITDA of $-2.90M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.07M |
|
$-3.10M |
|
$0.32M |
|
$-0.24M |
|
$3.19M |
|
$-3.12M |
|
$0.02M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.12M |
|
|
EBITDA |
$-2.90M |
13.75M |
|
13.75M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$5.54M |
|
$1.27M |
|
$3.64M |
|
$9.18M |
|
$2.44M |
|
-- |
|
$1.85M |
|
$4.30M |
|
$4.89M |
|
$4.83M |
|
$4.89M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$-3.05M |
|
$-0.01M |
|
$1.72M |
|
$5.59M |
|
$4.26M |
|
$-1.33M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-332.88% |
|
-4267.12% |
|
-4267.12% |
|
-- |
|
-4242.47% |
|
-4242.47% |
|
$-3.06M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.47 |
|
0.31 |
|
287.26 |
|
-63.39% |
|
-64.16% |
|
-33.73% |
|
-63.39% |
|
$0.34 |
|
$-0.22 |
|
$-0.22 |
|